Long-term maternal and child outcomes following postnatal SSRI treatment
Description
In this talk, Kate Liu examines the lasting effects of untreated postnatal depression. While SSRIs are commonly recommended for moderate to severe postnatal depression, concerns about their long-term safety in children create hesitations in treatment. To address this, she presents a study tracking over 60,000 mother-child pairs in Norway, investigating the impact of postnatal SSRI use on children’s emotional, behavioral, motor, and language development over the first five years of life. Her study design overcomes key limitations of previous research, providing a more comprehensive and reliable understanding of long-term child outcomes following postnatal SSRI use.
Learning Objectives
A. To understand postnatal depression and its treatment options
B. To understand the barriers preventing women from getting treatment
C. To recognize the benefits and risk of postnatal SSRI treatment